{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:05Z","timestamp":1786979825335,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T00:00:00Z","timestamp":1485561600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University Medical Center Utrecht"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1007\/s00228-017-2204-8","type":"journal-article","created":{"date-parts":[[2017,1,28]],"date-time":"2017-01-28T08:33:16Z","timestamp":1485592396000},"page":"573-580","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":70,"title":["High tacrolimus blood concentrations early after lung transplantation and the risk of kidney injury"],"prefix":"10.1007","volume":"73","author":[{"given":"M. A.","family":"Sikma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C.","family":"Hunault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"van de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. C.","family":"Verhaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kesecioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Meulenbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,28]]},"reference":[{"issue":"8","key":"2204_CR1","first-page":"3217","volume":"42","author":"M Paradela de la Morena","year":"2010","unstructured":"Paradela de la Morena M, La Torre Bravos De M, Prado RF, Delgado Roel M, Garc\u00eda Salcedo JA, Fieira Costa E et al (2010 Oct 1) Chronic kidney disease after lung transplantation: incidence, risk factors, and treatment. TPS Elsevier Inc 42(8):3217\u20133219","journal-title":"TPS Elsevier Inc"},{"issue":"1","key":"2204_CR2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2215\/CJN.04800512","volume":"8","author":"E Wehbe","year":"2013","unstructured":"Wehbe E, Duncan AE, Dar G, Budev M, Stephany B (2013 Jan 7) Recovery from AKI and short- and long-term outcomes after lung transplatation. Clinical Journal of the American Society of Nephrology American Society of Nephrology 8(1):19\u201325","journal-title":"Clinical Journal of the American Society of Nephrology American Society of Nephrology"},{"issue":"10","key":"2204_CR3","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","volume":"349","author":"AO Ojo","year":"2003","unstructured":"Ojo AO, Held PJ, Port FK, Wolfe RA, Leichtman AB, Young EW et al (2003 Sep 4) Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349(10):931\u2013940","journal-title":"N Engl J Med"},{"issue":"9","key":"2204_CR4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1002\/lt.21821","volume":"15","author":"P Sharma","year":"2009","unstructured":"Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS (2009 Sep) Renal outcomes after liver transplantation in the model for end-stage liver disease era. Liver Transpl 15(9):1142\u20131148","journal-title":"Liver Transpl"},{"issue":"7","key":"2204_CR5","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s001340051281","volume":"26","author":"A De Mendonca","year":"2000","unstructured":"De Mendonca A, Vincent JL, Suter PM, Moreno R, Dearden NM, Antonelli M et al (2000 Jul 28) Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med Springer-Verlag 26(7):915\u2013921","journal-title":"Intensive Care Med Springer-Verlag"},{"issue":"5","key":"2204_CR6","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00467-009-1402-8","volume":"25","author":"S Leroy","year":"2010","unstructured":"Leroy S, Isapof A, Fargue S, Fakhoury M, Bensman A, Desch\u00eanes G et al (2010 Jan 21) Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics. Pediatr Nephrol 25(5):965\u2013969","journal-title":"Pediatr Nephrol"},{"issue":"3","key":"2204_CR7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-199708150-00012","volume":"64","author":"AD Mayer","year":"1997","unstructured":"Mayer AD, Dmitrewski J, Squifflet JP, Besse T, Grabensee B, Klein B et al (1997 Aug 15) Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group. Transplantation 64(3):436\u2013443","journal-title":"Transplantation"},{"key":"2204_CR8","doi-asserted-by":"crossref","unstructured":"Haddad EM, McAlister VC, Renouf E, Malthaner R, Kjaer MS, Gluud LL. (2006) Cyclosporin versus tacrolimus for liver transplanted patients. In: McAlister V (ed) Cochrane Database Syst Rev. Wiley, Ltd, Chichester, UK (4):CD005161","DOI":"10.1002\/14651858.CD005161.pub2"},{"issue":"3","key":"2204_CR9","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1055\/s-2007-1013136","volume":"47","author":"F Kur","year":"1999","unstructured":"Kur F, Reichenspurner H, Meiser BM, Welz A, F\u00fcrst H, M\u00fcller C et al (1999 Jun) Tacrolimus (FK506) as primary immunosuppressant after lung transplantation. Thorac Cardiovasc Surg 47(3):174\u2013178","journal-title":"Thorac Cardiovasc Surg"},{"key":"2204_CR10","volume":"5","author":"L Penninga","year":"2013","unstructured":"Penninga L, Penninga EI, M\u00f8ller CH, Iversen M, Steinbr\u00fcchel DA, Gluud C (2013) Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients. Cochrane Database Syst Rev 5:CD008817","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2204_CR11","first-page":"277","volume":"32","author":"I Kaczmarek","year":"2013","unstructured":"Kaczmarek I, Zaruba M-M, Beiras-Fernandez A, Reimann R, Nickel T, Grinninger C et al (2013 Mar 1) Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus\/mycophenolate mofetil) after heart transplantation: 5-year results. HEALUN Elsevier 32(3):277\u2013284","journal-title":"HEALUN Elsevier"},{"issue":"12","key":"2204_CR12","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1517\/17425247.2015.1106687","volume":"12","author":"MA Sikma","year":"2015","unstructured":"Sikma MA, van Maarseveen EM, Donker DW, Meulenbelt J (2015 Dec) Letter to the editor: \u201cimmunosuppressive drug therapy\u2014biopharmaceutical challenges and remedies\u201d. Expert Opin Drug Deliv Informa Healthcare 12(12):1955\u20131957","journal-title":"Expert Opin Drug Deliv Informa Healthcare"},{"issue":"11","key":"2204_CR13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","volume":"41","author":"U Christians","year":"2002","unstructured":"Christians U, Jacobsen W, Benet LZ (2002) Mechanisms of clinically relevant drug interactions associated with tacrolimus. Clin Pharmacokinet 41(11):813\u2013851","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"2204_CR14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/FPC.0b013e328307c26e","volume":"18","author":"DR Kuypers","year":"2008","unstructured":"Kuypers DR, de Jonge H, Naesens M, Vanrenterghem Y (2008 Oct) Effects of CYP3A5 and MDR1 single nucleotide polymorphisms on drug interactions between tacrolimus and fluconazole in renal allograft recipients. Pharmacogenet Genomics 18(10):861\u2013868","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"2204_CR15","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1111\/ajt.13309","volume":"15","author":"MA Sikma","year":"2015","unstructured":"Sikma MA, van Maarseveen EM, van de Graaf EA, Kirkels JH, Verhaar MC, Donker DW et al (2015 Jun 4) Pharmacokinetics and toxicity of tacrolimus early after heart and lung transplantation. Am J Transplant 15(9):2301\u20132313","journal-title":"Am J Transplant"},{"key":"2204_CR16","first-page":"399","volume":"18","author":"GI Snell","year":"2013","unstructured":"Snell GI, Ivulich S, Mitchell L, Westall GP, Levvey BJ (2013) Evolution to twice daily bolus intravenous tacrolimus: optimizing efficacy and safety of calcineurin inhibitor delivery early post lung transplant. Ann Transplant International Scientific Information, Inc 18:399\u2013407","journal-title":"Ann Transplant International Scientific Information, Inc"},{"issue":"9","key":"2204_CR17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/j.1600-6143.2008.02342.x","volume":"8","author":"C Lefaucheur","year":"2008","unstructured":"Lefaucheur C, Nochy D, Amrein C, Chevalier P, Guillemain R, Cherif M et al (2008) Renal Histopathological lesions after lung transplantation in patients with cystic fibrosis. Am J Transplant 8(9):1901\u20131910","journal-title":"Am J Transplant"},{"issue":"8","key":"2204_CR18","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/thx.2007.092056","volume":"63","author":"G Meachery","year":"2008","unstructured":"Meachery G, De Soyza A, Nicholson A, Parry G, Hasan A, Tocewicz K et al (2008 Aug 1) Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 63(8):725\u2013731","journal-title":"Thorax"},{"issue":"5","key":"2204_CR19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.healun.2005.12.004","volume":"25","author":"Y Wang","year":"2006","unstructured":"Wang Y, Kurichi JE, Blumenthal NP, Ahya VN, Christie JD, Pochettino A et al (2006 May) Multiple variables affecting blood usage in lung transplantation. J Heart Lung Transplant 25(5):533\u2013538","journal-title":"J Heart Lung Transplant"},{"issue":"1\u20133","key":"2204_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000322161","volume":"31","author":"F Garzotto","year":"2011","unstructured":"Garzotto F, Piccinni P, Cruz D, Gramaticopolo S, Dal Santo M, Aneloni G et al (2011) RIFLE-based data collection\/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit. Blood Purif 31(1\u20133):159\u2013171","journal-title":"Blood Purif"},{"issue":"24","key":"2204_CR21","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1056\/NEJMoa020009","volume":"349","author":"BJ Nankivell","year":"2003","unstructured":"Nankivell BJ, Borrows RJ, Fung CLS, O\u2019Connell PJ, Allen RDM, Chapman JR (2003 Dec 11) The natural history of chronic allograft nephropathy. N Engl J Med 349(24):2326\u20132333","journal-title":"N Engl J Med"},{"issue":"4","key":"2204_CR22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/11317550-000000000-00000","volume":"49","author":"DCE Staatz","year":"2010","unstructured":"Staatz DCE, Goodman LK, Tett SE (2010) Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: part II. Clinical Pharmacokinetics. Springer International Publishing 49(4):207\u2013221","journal-title":"Clinical Pharmacokinetics. Springer International Publishing"},{"key":"2204_CR23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/FPC.0b013e3282f9ac01","volume":"18","author":"M Fukudo","year":"2008","unstructured":"Fukudo M, Yano I, Yoshimura A (2008 Apr 5) Impact of MDR1 and CYP3A5 on the oral clearanceof tacrolimus and tacrolimus-related renal dysfunction in adult living-donor liver transplant patients. Pharmacogenet Genomics 18:413\u2013423","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"2204_CR24","first-page":"226","volume":"512","author":"Y Shi","year":"2013","unstructured":"Shi Y, Li Y, Tang J, Zhang J, Zou Y, Cai B et al (2013 Jan 10) Influence of CYP3A4, CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics and early renal dysfunction in liver transplant recipients. Gene Elsevier BV 512(2):226\u2013231","journal-title":"Gene Elsevier BV"},{"issue":"7","key":"2204_CR25","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/ndt\/gfm133","volume":"22","author":"MS Joy","year":"2007","unstructured":"Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V (2007 Apr 20) Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrology Dialysis Transplantation 22(7):1963\u20131968","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"3","key":"2204_CR26","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","volume":"57","author":"H Zahir","year":"2004","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ (2004 Mar) Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Br J Clin Pharmacol 57(3):298\u2013309","journal-title":"Br J Clin Pharmacol"},{"key":"2204_CR27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1056-8719(02)00158-2","volume":"46","author":"H Zahir","year":"2001","unstructured":"Zahir H, Nand RA, Brown KF, Tattam BN (2001) Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J Pharmacol Toxicol Methods 46:27\u201335","journal-title":"J Pharmacol Toxicol Methods"},{"issue":"5","key":"2204_CR28","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/01.CCM.0000059724.08290.51","volume":"31","author":"HJ Van Leeuwen","year":"2003","unstructured":"Van Leeuwen HJ, Heezius ECJM, Dallinga GM, van Strijp JAG, Verhoef J, van Kessel KPM (2003 May) Lipoprotein metabolism in patients with severe sepsis. Crit Care Med 31(5):1359\u20131366","journal-title":"Crit Care Med"},{"issue":"6","key":"2204_CR29","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00007691-200412000-00003","volume":"26","author":"C Dansirikul","year":"2004","unstructured":"Dansirikul C, Staatz CE, Duffull SB, Taylor PJ, Lynch SV, Tett SE (2004 Dec) Sampling times for monitoring tacrolimus in stable adult liver transplant recipients. Ther Drug Monit 26(6):593\u2013599","journal-title":"Ther Drug Monit"},{"issue":"1","key":"2204_CR30","first-page":"1","volume":"7","author":"BVM Dasari","year":"2016","unstructured":"Dasari BVM, Hodson J, Nassir A, Widmer J, Isaac J, Mergentel H et al (2016) Variations in practice to therapeutic monitoring of tacrolimus following primary adult liver transplantation. Int J Organ Transplant Med Avicenna Organ Transplantation Institute 7(1):1\u20138","journal-title":"Int J Organ Transplant Med Avicenna Organ Transplantation Institute"},{"issue":"4","key":"2204_CR31","first-page":"314","volume":"35","author":"E Rey","year":"1998","unstructured":"Rey E, Tr\u00e9luyer JM, Pons G (1998) Drug disposition in cystic fibrosis. Clin Pharmacokinet 35(4):314\u2013329","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2204_CR32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/11594760-000000000-00000","volume":"51","author":"C Monchaud","year":"2012","unstructured":"Monchaud C, de Winter BC, Knoop C, Estenne M, Reynaud-Gaubert M, Pison C et al (2012 Mar 1) Population pharmacokinetic modelling and design of a Bayesian estimator for therapeutic drug monitoring of tacrolimus in lung transplantation. Clin Pharmacokinet 51(3):175\u2013186","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2204_CR33","first-page":"772","volume":"44","author":"YH Lin","year":"2012","unstructured":"Lin YH, Lin CC, Wang CC, Wang SH, Liu YW, Yong CC et al (2012) The 4-week serum creatinine level predicts long-term renal dysfunction after adult living donor liver transplantation. TPS. Elsevier Inc 44(3):772\u2013775","journal-title":"TPS. Elsevier Inc"},{"issue":"2","key":"2204_CR34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1600-6143.2008.02493.x","volume":"9","author":"JM Neuberger","year":"2009","unstructured":"Neuberger JM, Mamelok RD, Neuhaus P, Pirenne J, Samuel D, Isoniemi H et al (2009 Feb) Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the \u2018ReSpECT\u2019 study. Am J Transplant 9(2):327\u2013336","journal-title":"Am J Transplant"},{"issue":"4","key":"2204_CR35","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00448.2010","volume":"301","author":"ZH Endre","year":"2011","unstructured":"Endre ZH, Pickering JW, Walker RJ (2011 Oct) Clearance and beyond: the complementary roles of GFR measurement and injury biomarkers in acute kidney injury (AKI). Am J Physiol Renal Physiol American Physiological Society 301(4):F697\u2013F707","journal-title":"Am J Physiol Renal Physiol American Physiological Society"},{"issue":"3","key":"2204_CR36","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc12777","volume":"17","author":"G Bragadottir","year":"2013","unstructured":"Bragadottir G, Redfors B, Ricksten S-E (2013) Assessing glomerular filtration rate (GFR) in critically ill patients with acute kidney injury\u2014true GFR versus urinary creatinine clearance and estimating equations. Crit Care 17(3):R108","journal-title":"Crit Care"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-017-2204-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-017-2204-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T05:15:08Z","timestamp":1498367708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-017-2204-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,28]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["2204"],"URL":"https:\/\/doi.org\/10.1007\/s00228-017-2204-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,28]]}}}